Acquisition of HIV-1 infection Throughout study [clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c]

Acquisition of HIV-1 infection Throughout study [clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c]

Three doses of MRKAd5 HIV-1 gag/pol/nef vaccine
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c
clinicaltrials:NCT00413725
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Acquisition of HIV-1 infection Throughout study [clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c]

Three doses of MRKAd5 HIV-1 gag/pol/nef vaccine
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c
Bio2RDF identifier
9589ebf078f81c7c908c0e79dcf2cc3c
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c
measure [clinicaltrials_vocabulary:measure]
Acquisition of HIV-1 infection
time frame [clinicaltrials_vocabulary:time-frame]
description
Three doses of MRKAd5 HIV-1 gag/pol/nef vaccine
identifier
clinicaltrials_resource:9589ebf078f81c7c908c0e79dcf2cc3c
title
Acquisition of HIV-1 infection Throughout study
@en
inDataset
type
label
Acquisition of HIV-1 infection ...... 9ebf078f81c7c908c0e79dcf2cc3c]
@en